Molecular properties that influence the oral bioavailability of drug candidates.
暂无分享,去创建一个
[1] L. Goodman,et al. The Pharmacological Basis of Therapeutics , 1941 .
[2] R. Lennox,et al. Structure and electrochemical properties of microfiltration filter-lipid membrane systems , 1982 .
[3] R. Gaylord. unpublished results , 1985 .
[4] W. Stigelman,et al. Goodman and Gilman's the Pharmacological Basis of Therapeutics , 1986 .
[5] J. Bloomer,et al. Lauric acid as a model substrate for the simultaneous determination of cytochrome P450 2E1 and 4A in hepatic microsomes. , 1994, Chemical research in toxicology.
[6] R. Borchardt,et al. How structural features influence the biomembrane permeability of peptides. , 1996, Journal of pharmaceutical sciences.
[7] K. Luthman,et al. Correlation of drug absorption with molecular surface properties. , 1996, Journal of pharmaceutical sciences.
[8] Pravin Chaturvedi,et al. Design principles for orally bioavailable drugs , 1996 .
[9] Ajay,et al. Can we learn to distinguish between "drug-like" and "nondrug-like" molecules? , 1998, Journal of medicinal chemistry.
[10] K Gubernator,et al. Physicochemical high throughput screening: parallel artificial membrane permeation assay in the description of passive absorption processes. , 1998, Journal of medicinal chemistry.
[11] K. Iseki,et al. A general approach for the prediction of the intestinal absorption of drugs: regression analysis using the physicochemical properties and drug-membrane electrostatic interaction. , 1998, Journal of pharmaceutical sciences.
[12] D. E. Clark,et al. Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 2. Prediction of blood-brain barrier penetration. , 1999, Journal of pharmaceutical sciences.
[13] T. Baillie,et al. Is the role of the small intestine in first-pass metabolism overemphasized? , 1999, Pharmacological reviews.
[14] T. Vidmar,et al. Strategies toward predicting peptide cellular permeability from computed molecular descriptors. , 1999, The journal of peptide research : official journal of the American Peptide Society.
[15] D. E. Clark. Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 1. Prediction of intestinal absorption. , 1999, Journal of pharmaceutical sciences.
[16] C. Lipinski. Drug-like properties and the causes of poor solubility and poor permeability. , 2000, Journal of pharmacological and toxicological methods.
[17] John G. Topliss,et al. QSAR Model for Drug Human Oral Bioavailability1 , 2000 .
[18] K. Luthman,et al. Virtual screening of intestinal drug permeability. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[19] J J Baldwin,et al. Prediction of drug absorption using multivariate statistics. , 2000, Journal of medicinal chemistry.
[20] P. Selzer,et al. Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. , 2000, Journal of medicinal chemistry.
[21] J. Topliss,et al. QSAR model for drug human oral bioavailability. , 2000, Journal of medicinal chemistry.
[22] M. Machida,et al. High Throughput Prediction of Oral Absorption: Improvement of the Composition of the Lipid Solution Used in Parallel Artificial Membrane Permeation Assay , 2001, Journal of biomolecular screening.
[23] P. Jeffrey,et al. Utility of metabolic stability screening: comparison of in vitro and in vivo clearance , 2001, Xenobiotica; the fate of foreign compounds in biological systems.
[24] K. Brouwer,et al. Pharmacokinetic and Pharmacodynamic Implications of P‐glycoprotein Modulation , 2001, Pharmacotherapy.
[25] Y. Ru,et al. Azepanone-based inhibitors of human and rat cathepsin K. , 2001, Journal of medicinal chemistry.
[26] B. Faller,et al. High-throughput permeability pH profile and high-throughput alkane/water log P with artificial membranes. , 2001, Journal of medicinal chemistry.
[27] R. Borchardt,et al. Transport characteristics of peptides and peptidomimetics: I. N-methylated peptides as substrates for the oligopeptide transporter and P-glycoprotein in the intestinal mucosa. , 2001, The journal of peptide research : official journal of the American Peptide Society.
[28] F. Lombardo,et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. , 2001, Advanced drug delivery reviews.
[29] U Norinder,et al. Experimental and computational screening models for the prediction of intestinal drug absorption. , 2001, Journal of medicinal chemistry.
[30] C. Decker,et al. Prediction of pharmacokinetic properties using experimental approaches during early drug discovery. , 2001, Current opinion in chemical biology.
[31] R. Borchardt,et al. Effect of Restricted Conformational Flexibility on the Permeation of Model Hexapeptides Across Caco-2 Cell Monolayers , 1997, Pharmaceutical Research.
[32] Kristina Luthman,et al. Prediction of Membrane Permeability to Peptides from Calculated Dynamic Molecular Surface Properties , 1999, Pharmaceutical Research.
[33] Kristina Luthman,et al. Polar Molecular Surface Properties Predict the Intestinal Absorption of Drugs in Humans , 1997, Pharmaceutical Research.